These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29088451)

  • 81. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
    Chang WS; Schollum J; White DH; Solanki KK
    Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.
    Saigusa R; Asano Y; Nakamura K; Miura S; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Noda S; Aozasa N; Akamata K; Sumida H; Miyazaki M; Tamaki Z; Yanaba K; Kuwano Y; Sato S
    J Dermatol; 2015 May; 42(5):524-7. PubMed ID: 25720827
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Epidermal thickness in systemic sclerosis and morphoea.
    Morley SM; Gaylarde PM; Sarkany I
    Clin Exp Dermatol; 1985 Jan; 10(1):51-7. PubMed ID: 3987086
    [No Abstract]   [Full Text] [Related]  

  • 84. Current and future direction in the management of scleroderma.
    Brady SM; Shapiro L; Mousa SA
    Arch Dermatol Res; 2016 Sep; 308(7):461-71. PubMed ID: 27139430
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.
    Tomimura S; Ogawa F; Iwata Y; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Immune deficiency states in autoimmune diseases].
    Niwa Y; Kano T
    Saishin Igaku; 1971 Mar; 26(3):591-607. PubMed ID: 4100713
    [No Abstract]   [Full Text] [Related]  

  • 87. [Lung disease secondary to morphea en coup de sabre, a form of localized scleroderma].
    Hernández Pérez JM; Acosta Fernández O
    Arch Bronconeumol; 2009 Aug; 45(8):411-2. PubMed ID: 19398256
    [No Abstract]   [Full Text] [Related]  

  • 88. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T; Kähäri VM; Black C; Vuorio E
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A review of the clinically distinguishing features of nodular or keloidal scleroderma in systemic sclerosis.
    Richarz NA; Olivé A; García-Patos V; Quirant B; Fernández Figueras MT; Bielsa I
    Australas J Dermatol; 2020 May; 61(2):e269-e273. PubMed ID: 31984476
    [No Abstract]   [Full Text] [Related]  

  • 90. Case of anti-RuvBL1/2 antibody-positive morphea and polymyositis.
    Takahashi T; Nakanishi T; Hamaguchi Y; Tanaka T; Fujimoto N
    J Dermatol; 2017 Oct; 44(10):1188-1190. PubMed ID: 27786369
    [No Abstract]   [Full Text] [Related]  

  • 91. Serological changes in progressive systemic sclerosis.
    Davis P; Jayson MI
    Rheumatol Rehabil; 1976 Feb; 15(1):45-50. PubMed ID: 1251106
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Quantifying Skin Stiffness in Graft-Versus-Host Disease, Morphea, and Systemic Sclerosis Using Acoustic Radiation Force Impulse Imaging and Shear Wave Elastography.
    Cardones AR; Hall RP; Sullivan KM; Hooten J; Lee SY; Liu B; Green CL; Chao NJ; Rowe Nichols K; Bañez LL; Shah A; Leung N; Palmeri ML
    J Invest Dermatol; 2021 Apr; 141(4):924-927.e2. PubMed ID: 32950506
    [No Abstract]   [Full Text] [Related]  

  • 93. Pathogenesis of scleroderma. Current concepts.
    Lee EB; Anhalt GJ; Voorhees JJ; Diaz LA
    Int J Dermatol; 1984 Mar; 23(2):85-9. PubMed ID: 6698691
    [No Abstract]   [Full Text] [Related]  

  • 94. Questions raised by a case of adult-onset linear nodular scleroderma.
    Marcelus C; Jimenez A; Zussman J; Hansen CB; Sontheimer RD
    Dermatol Online J; 2022 Oct; 28(5):. PubMed ID: 36809134
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Body mass index and body surface area in scleroderma patients.
    Wcisło-Dziadecka D; Kaźmierczak A; Zbiciak-Nylec M; Brzoza Z; Brzezińska-Wcisło L
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):e164-e165. PubMed ID: 29080322
    [No Abstract]   [Full Text] [Related]  

  • 96. A case of systemic sclerosis with linear scleroderma developing after fracture surgery.
    Saigusa R; Asano Y; Yamashita T; Sumida H; Miyazaki M; Sato S
    Eur J Dermatol; 2017 Apr; 27(2):200-201. PubMed ID: 28251893
    [No Abstract]   [Full Text] [Related]  

  • 97. Nodular scleroderma.
    Krell JM; Solomon AR; Glavey CM; Lawley TJ
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 2):343-5. PubMed ID: 7829737
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Internal involvement in localized scleroderma.
    Dehen L; Roujeau JC; Cosnes A; Revuz J
    Medicine (Baltimore); 1994 Sep; 73(5):241-5. PubMed ID: 7934808
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A To-Do List at Diagnosis of Systemic Sclerosis with Positive Anti-RNA Polymerase III Antibodies.
    Kuwana M
    J Rheumatol; 2017 May; 44(5):550-552. PubMed ID: 28461517
    [No Abstract]   [Full Text] [Related]  

  • 100. Morphaea-like cutaneous changes in a patient with systemic scleroderma.
    Ikai K; Tagami H; Imamura S; Hayakawa M
    Dermatologica; 1979; 158(6):438-42. PubMed ID: 467762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.